Compound Summary
L-valine
Compound Information
L-valine
Compound Name: | L-valine |
Compound CID: | 6287 |
Synonyms: | L-valine valine 72-18-4 (S)-Valine H-Val-OH More... |
Iupac Name: | (2S)-2-amino-3-methylbutanoic acid |
InChI: | InChI=1S/C5H11NO2/c1-3(2)4(6)5(7)8/h3-4H,6H2,1-2H3,(H,7,8)/t4-/m0/s1 |
InChIKey: | KZSNJWFQEVHDMF-BYPYZUCNSA-N |
Canonical Smiles: | CC(C)C(C(=O)O)N |
Isomeric Smiles: | CC(C)[C@@H](C(=O)O)N |
Molecular Weight: | 117.15 |
Molecular Formula: | C5H11NO2 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
L-valine
Molecular Weight: | 117.15 |
Molecular Formula: | C5H11NO2 |
Hydrogen Bond Donor Count: | 2 |
Hydrogen Bond Acceptor Count: | 3 |
Rotatable Bond Count: | 2 |
Heavy Atom Count: | 8 |
Complexity: | 90.4 |
Synonyms
L-valine
| L-valine | L-valine |
|---|---|
L-valine |
valine |
72-18-4 |
(S)-Valine |
H-Val-OH |
(S)-2-Amino-3-methylbutanoic acid |
2-Amino-3-methylbutyric acid |
(2S)-2-amino-3-methylbutanoic acid |
(S)-2-Amino-3-methylbutyric acid |
L-alpha-Amino-beta-methylbutyric acid |
Valinum Latin |
Valina Spanish |
Valine (VAN) |
Butanoic acid, 2-amino-3-methyl- |
Valine USAN:INN |
L-valin |
VALINE, L- |
L(+)-alpha-Aminoisovaleric acid |
(S)-alpha-Amino-beta-methylbutyric acid |
Butanoic acid, 2-amino-3-methyl-, (S)- |
2-Amino-3-methylbutyric acid, (S)- |
2-Amino-3-methylbutanoic acid, (S)- |
UNII-HG18B9YRS7 |
7004-03-7 |
NSC 76038 |
(L)-valine |
2-Amino-3-methylbutanoic acid (VAN) |
CHEBI:16414 |
L-2-Amino-3-methylbutanoic acid |
l-(+)-alpha-Aminoisovaleric acid |
L-2-Aminoisovaleric Acid |
MFCD00064220 |
val |
valina |
HG18B9YRS7 |
(S)-alpha-Aminoisovaleric acid |
NSC-76038 |
Valine (L-Valine) |
L-Val |
Valinum |
2-aminoisovaleric acid |
(2S)-2-amino-3-methylbutanoate |
alpha-aminoisovaleric acid |
EINECS 200-773-6 |
2-Amino-3-methyl-butyric acid |
2-amino-3-methylbutanoate |
Racemic valine |
L-(+)-a-Aminoisovaleric acid |
s-valin |
L-(+)-.alpha.-Aminoisovaleric acid |
L-a-Amino-b-methylbutyric acid |
HSDB 7800 |
3h-l-valine |
(S)-a-Amino-b-methylbutyric acid |
L-Valine; |
L-Valine, FCC |
Valine (USP) |
(+)-valine |
L-Valine,(S) |
L-Valine, USP Grade |
1t4s |
L-Valine (JP17) |
L-Valine, 99% |
(S)-Val |
L-Val-4 |
L-VAL-OH |
2-Amino-3-methylbutyrate |
bmse000052 |
bmse000811 |
bmse000860 |
EC 200-773-6 |
L-(+)-a-Aminoisovalerate |
L-a-Amino-b-methylbutyrate |
SCHEMBL8516 |
(S)-A-Aminoisovaleric acid |
H-Val-2-Chlorotrityl Resin |
(S)-?-Aminoisovaleric acid |
2-Aminoisovaleric acid,(S) |
CHEMBL43068 |
(S)-a-Amino-b-methylbutyrate |
L-(+)-alpha-Aminoisovalerate |
L-iso-C3H7CH(NH2)COOH |
GTPL4794 |
(S)-2-Amino-3-methylbutyrate |
(S)-2-Amino-3-methylbutanoate |
L-Valine, Cell Culture Reagent |
DTXSID40883233 |
L-alpha-Amino-beta-methylbutyrate |
(S)-2-amino-3-methyl-Butanoate |
Pharmakon1600-01301009 |
ZINC895099 |
HY-N0717 |
(S)-alpha-Amino-beta-methylbutyrate |
(S)-2-amino-3-methyl-butyric acid |
BDBM50463208 |
NSC760111 |
s5628 |
(S)-2-amino-3-methyl-Butanoic acid |
L-Valine, 98.5-101.5% |
AKOS015841564 |
AM82363 |
CCG-266067 |
CS-W020706 |
DB00161 |
L-Valine, 99%, natural, FCC, FG |
MCULE-9143825935 |
NSC-760111 |
NCGC00344520-01 |
AS-12787 |
K180 |
L-Valine, BioUltra, >=99.5% (NT) |
L-Valine, SAJ special grade, >=98.5% |
AB0014076 |
DB-029989 |
L-Valine, reagent grade, >=98% (HPLC) |
L-Valine, Vetec(TM) reagent grade, >=98% |
C00183 |
D00039 |
M02950 |
V-1800 |
(S)-(+)-2-AMINO-3-METHYLBUTYRIC ACID |
064V220 |
192321-EP2272829A2 |
Q483752 |
Q-100919 |
L-Valine, certified reference material, TraceCERT(R) |
F8889-8698 |
Valine, European Pharmacopoeia (EP) Reference Standard |
Z1250208665 |
1B39571B-0AE8-4A9A-AE80-4B898D11A981 |
UNII-0O72R8RF8A component KZSNJWFQEVHDMF-BYPYZUCNSA-N |
UNII-4CA13A832H component KZSNJWFQEVHDMF-BYPYZUCNSA-N |
UNII-66PZQ62YA6 component KZSNJWFQEVHDMF-BYPYZUCNSA-N |
UNII-N7U7BXP2OI component KZSNJWFQEVHDMF-BYPYZUCNSA-N |
L-Valine, United States Pharmacopeia (USP) Reference Standard |
L-Valine, Pharmaceutical Secondary Standard; Certified Reference Material |
L-Valine, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, 98.5-101.0% |
L-Valine, PharmaGrade, Ajinomoto, EP, JP, USP, manufactured under appropriate GMP controls for Pharma or Biopharmaceutical production, suitable for cell culture |
Experimental Data
L-valine
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 5.000000000000000 | mM | 27.370000000000000 | 28.590000000000000 | 0.040000000000000 | 31.000000000000000 | 31.000000000000000 | 0.000000000000000 | S | N2 | 26620638 | Active | |
| Caenorhabditis elegans | 1.000000000000000 | mM | 13.000000000000000 | NS | N2 | 25643626 | Inactive | ||||||
| Caenorhabditis elegans | 10.000000000000000 | mM | -1.000000000000000 | S | N2 | 25643626 | Inactive | ||||||
| Caenorhabditis elegans | 5.000000000000000 | mM | 8.000000000000000 | S | N2 | 25643626 | Active |
Experimental Data Visualization
L-valine
Statistics Data
L-valine
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 13.000000000000000 | 0.000000000000000 | 2 | 4 |
Statistics Data Visualization
L-valine
